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ABSTRACT
Background: To update the findings of relative risk associated with smoking for all-cause mortality and that for lung cancer by
considering longitudinal changes in smoking status during follow-up.
Methods: Data from the JPHC study of 98,747 middle-aged Japanese adults, which started in 1990–1993, were analyzed. The
information on smoking status was obtained from three questionnaire surveys (baseline, the 5th year, and the 10th year after the
start of follow-up). A Poisson regression model was used to investigate the impact of smoking on mortality from all causes and
lung cancer using two approaches. Model 1 used information only from baseline, while model 2 used the updated smoking
status from all three surveys.
Results: During the 15-year follow-up, 10,702 all-cause deaths (including 870 lung cancer cases) were identified. We compared
the results obtained from two models. The relative risks associated with former smokers versus never smokers were 1.42 (95%
confidence interval [CI], 1.31–1.54) among men and 1.46 (95% CI, 1.23–1.73) among women for all-cause mortality and 2.98
(95% CI, 2.09–4.24) among men and 1.83 (95% CI, 0.92–3.64) among women for lung cancer mortality, as determined using
model 2. All of these were higher than the relative risks obtained from model 1. In addition, former smokers who had quit
smoking due to disease during follow-up had a higher mortality risk than continuous smokers did in this study.
Conclusions: The relative risks of all-cause mortality and mortality due to lung cancer among former smokers be higher than
previously documented based on updated smoking status data from repeated surveys.
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INTRODUCTION
Smoking, mainly of cigarettes, is a well-established preventable
risk factor for death and non-communicable diseases world-
wide.1–3 Several reviews have evaluated studies of smoking-
associated mortality and the benefits of smoking cessation.4–7
Improving lifestyle factors, such as smoking habits, reduces
disease risk, but empirical analyses supporting these associations
are currently lacking.
Although the hazard associated with smoking is substantial,
general cohort studies tend to underestimate the actual death
rates because they do not account for changes in smoking
status; smoking information is usually acquired only once at
baseline.8–12 Smoking habits that change during follow-up,
especially when current smokers quit, affect the apparent impact
of cessation. Although such problems can be reduced using repeat
surveys in cohort studies,13 a comparison of risk estimations
obtained from using updated or static data for individuals has not
yet been extensively investigated.7,14,15
Here, we evaluated smoking status from multiple surveys
during follow-up. Therefore, we could reclassify smoking status
according to current information. To update findings for smoking-
associated mortality, we report the relative risks for mortality
according to smoking status changes.
METHODS
Study population
The Japan Public Health Center-based prospective study on
cancer and cardiovascular diseases (JPHC Study) is a population-
based cohort of 140,420 adults with registered addresses in one of
30 administrative districts supervised by 11 public health center
areas. There are five public health center areas in the first group
(Cohort I), which started January 1, 1990, and six in the second
group (Cohort II), which started January 1, 1993.16 Cohort I
comprised all residents aged 40–59 years at baseline, except for
those in Tokyo, and Cohort II comprised all residents aged 40–69
years at baseline, except for those in Suita.16 Since participants
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from Tokyo and Suita public health centers were only evaluated
at 40 or 50 years of age, 16,844 residents from these age-biased
cohort areas were excluded from this analysis. After study
initiation, subjects deemed ineligible were excluded, including
those of non-Japanese nationality (n = 51), with late reports of
migration occurring before the start of follow-up (n = 174), with
incorrect birth data (n = 4), who refused to answer questions
(n = 12), with duplicate registrations (n = 4), and who refused
mail contact (n = 530). This study was approved by the
Institutional Review Board of the National Cancer Center, Japan
(Approval number: 2001-013, 14-038). Written informed consent
was obtained from all the participants in the JPHC study.
Baseline and additional surveys
Self-administered questionnaires evaluating socio-demographic
characteristics, personal medical history, smoking and drinking
history, diet, and other lifestyle-related factors were distributed
to all registered residents at baseline (called Q00).16 After
excluding 23,432 subjects with no baseline response, 565 without
available smoking status, and 57 lost to follow-up, 98,747
individuals (47,044 men and 51,703 women) were included in
this analysis. A follow-up survey was conducted during the 5th
year (Q05) after baseline to evaluate any changes in lifestyle
and obtain information on disease incidence during the first
5 years after the study started (called Period 1).16 In the 10th year
after baseline (Period 2), another follow-up survey (Q10) was
conducted.16
Follow-up and outcome
Since all surveys were conducted at regular 5-year intervals, we
defined the same follow-up duration after every survey. Thus, the
follow-up period defined for participants began on January 1,
1990 and ended on or before December 31, 2004 in Cohort I and
began on January 1, 1993 and ended on or before December 31,
2007 in Cohort II, so the longest follow-up duration was up to 15
years. Subjects were followed for residence status and vital status
through the residential registry.16 Cause of death was confirmed
with permission from death certificates and defined according to
the 10th revision of the International Classification of Disease.
The principal outcomes of this study were all-cause mortality and
that due to lung cancer (International Classification of Disease
code: C34).
Exposure definition
Smoking status was initially classified as never smoker, former
smoker, or current smoker. All study participants, including
responders and non-responders to resurveys (Q05 and Q10), were
followed for mortality. We used data on smoking status that were
collected only once at Q00 in model 1, whereas in model 2 we
used updated information about smoking status when available in
repeat questionnaires from all three surveys (Q00, Q05, and Q10).
Figure 1 shows the exposure differences on smoking status
between models 1 and 2. We also defined that the information on
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Model 1 used smoking status only from baseline.










Figure 1. The timeline of exposure
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In model 2, there were nine possible combinations of smoking
status changes in Period 1 from Q00 to Q05 and in Period 2 from
Q05 to Q10 (never smoker→never smoker, never smoker→
former smoker, never smoker→current smoker, former smok-
er→never smoker, former smoker→former smoker, former
smoker→current smoker, current smoker→never smoker, current
smoker→former smoker, current smoker→current smoker).
Those indicating that they were never smokers on follow-up
surveys but who indicated that they were former or current
smokers once before were defined as former smokers (n = 7,136;
7.2% of the sample).
Reasons for quitting smoking
In the JPHC study, reasons for quitting smoking were asked at
both Q05 and Q10.16 There were five possible responses: “Due
to illness”, “Considered unhealthy for the future”, “Considered
displeasing to surrounding people”, “Economic reasons”, and
“Others”. Here, we divided reasons for quitting smoking into two
categories based on whether participants quit smoking due to
illness or not.
Statistical methods
Statistical analyses were performed using nonparametric tests for
trends and using the Student t-test for continuous variables. For
analysis of mortality, individuals contributed to the person-years
at risk during the 15 years of follow-up, and they were censored
on the earliest date from death, moving out of the study areas, or
the end of follow-up. Person-years, number of deaths, and relative
risks and their 95% confidence intervals (CIs) for all-cause
and lung cancer-related mortality were aggregated and stratified
according to sex and smoking status. The analysis was conducted
by Poisson regression models in models 1 and 2 separately and
was adjusted by age in 5-year strata, public health center area,
alcohol consumption, body mass index, medication, history of
hypertension, history of diabetes, leisure-time sports, coffee
consumption, and green tea consumption, which were collected at
baseline.11,12
Life-threatening illness can cause smokers to quit, distorting
death rates among current and former smokers.5 Therefore,
we analyzed the impact of smoking status changes, focusing
particularly on the reasons for quitting. We restricted sub-
analyses to a 5-year follow-up from Q05 (Period 2) and another
5-year follow-up from Q10 until the study’s end (Period 3) in
order to estimate the relative risks of all-cause and lung cancer-
specific mortality in different smoking change combinations,
especially among never smoker→never smoker, former smoker→
former smoker, current smoker→former smoker, and current
smoker→current smoker. In the sub-analyses, smoking status
was classified by the information collected at Q05 or Q10,
respectively.
Significance tests were two-sided, and we defined a P-value
<0.05 as being statistically significant. All analyses were
performed with Stata software (version 13.1; Stata Corp, College
Station, TX, USA).
RESULTS
Changes in smoking status during the study period
Smoking statuses of participants at Q00, Q05, and Q10 are noted
in Table 1. The overall proportion of current smokers during
these 10 years decreased from 52.1% to 39.0% in men and from
6.1% to 4.3% in women. Accordingly, the proportion of former
smokers increased from 23.9% to 39.0% in men and from 1.7%
to 4.1% in women.
History and cigarettes smoked daily by smoking
status
Table 2 presents the information on medical history and daily
cigarette consumption. Overall, 2,950 men and 587 women
during Period 1 and 2,853 men and 525 women during Period 2
reported quitting smoking during the two adjacent surveys.
There was a great number of participants reporting a medical
history of any serious diseases, such as cancer, diabetes mellitus,
stroke, ischemic heart disease, and hepatitis or cirrhosis. Those
new quitters (current smoker→former smoker) who quit smoking
during Period 1 (19.3%) and Period 2 (27.0%) in men were
highest among all subgroups. Similarly, among both persistent
quitters (former smoker→former smoker: 12.2% in Period 1 and
19.0% in Period 2) and new quitters (current smoker→former
smoker: 12.1% in Period 1 and 16.4% in Period 2), the proportion
of women with a medical history was significantly higher than
for continuous smokers (current smoker→current smoker: 7.6%
in Period 1 and 11.5% in Period 2). Since the reason for quitting
smoking was asked at both Q05 and Q10 for former smokers,
we calculated the proportion of new quitters (current smoker→
former smoker) who quit smoking due to illness. The illnesses
Table 1. Survey respondents on smoking status by survey period and sex
Baseline 5-year follow-up 10-year follow-up
Number of participants (%) Number of participants (%) Number of participants (%)
Men
Responder 47,044 (100) 38,636 (100) 36,951 (100)
Never smoker 11,290 (24.0) 8,797 (22.8) 8,159 (22.1)
Former smoker 11,257 (23.9) 12,143 (31.4) 14,395 (39.0)
Current smoker 24,497 (52.1) 17,696 (45.8) 14,397 (39.0)
Non-responder 0 6,670 5,952
Total 47,044 45,306 42,903
Women
Responder 51,703 (100) 44,980 (100) 43,783 (100)
Never smoker 47,649 (92.2) 41,352 (91.9) 40,102 (91.6)
Former smoker 882 (1.7) 1,348 (3.0) 1,795 (4.1)
Current smoker 3,172 (6.1) 2,280 (5.1) 1,886 (4.3)
Non-responder 0 5,881 5,775
Total 51,703 50,861 49,558
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included some mild diseases, which were not pointed out in
details in questionnaires, as well as the serious diseases
mentioned above.
Table 2 also shows the mean number of cigarettes smoked
daily. The means for persistent quitters (16 in men and 9 in
women) and new quitters (20 in men and 12 in women) were
lower than those for continuous smokers (22 in men and 16
in women) during Period 1 for both sexes. We therefore
hypothesized that light smokers tended to quit smoking. However,
there were no differences between former and continuous smokers
during Period 2.
Since medical history refers to the most recent 5 years in the
5-year follow-up survey but refers to all the past until Q10 in
10-year follow-up survey, the percentage from Period 2 is
higher compared to Period 1 because of the different definition of
history.
Relative risk by smoking status
There were 7,039 deaths in men and 3,663 deaths in women
followed over a mean of 14.2 years (653,687 person-years for
men and 747,526 person-years for women) documented during
the study period. Results from the two approaches are shown in
Table 3. In model 1, data from individuals were divided by
attended age and classified only once by the Q00 smoking status.
In model 2, data for each individual were divided by attended age
and the three periods; smoking status was therefore reclassified
based on current information. Thus, although the total number of
person-years, number of deaths, and crude mortality were the
same, the distribution of those in each smoking category was
different between the two approaches. Compared with never
smokers, the relative risks for all-cause death among current
smokers were 1.79 (95% CI, 1.66–1.92) for men and 1.93 (95%
CI, 1.70–2.19) for women in model 1 and 1.74 (95% CI,
1.61–1.89) for men and 1.91 (95% CI, 1.67–2.19) for women
in model 2. Comparing former smokers to never smokers, the
relative risks from model 2 were 1.42 (95% CI, 1.31–1.54) for
men and 1.46 (95% CI, 1.23–1.73) for women, and both relative
risks were greater than those from model 1 (1.22; 95% CI,
1.12–1.32 for men and 1.43; 95% CI, 1.13–1.81 for women).
As shown in Table 3, there were 677 deaths among men and
193 deaths among women from lung cancer. Compared with
never smokers, the relative risks for lung cancer-related mortality
among current smokers were 4.70 (95% CI, 3.43–6.44) for men
and 3.28 (95% CI, 2.12–5.05) for women in model 1 and 4.69
(95% CI, 3.32–6.62) for men and 3.21 (95% CI, 2.03–5.07) for
women in model 2. The relative risks among former smokers
were 2.98 (95% CI, 2.09–4.24) for men and 1.83 (95% CI,
0.92–3.64) for women in model 2; both were greater than those
from model 1 (1.90; 95% CI, 1.34–2.72 for men and 0.77; 95%
CI, 0.19–3.13 for women).
Relative risks by reasons for quitting smoking
Table 4 shows that 3,537 participants quit smoking during Period
1 and that 2,318 participants (951 because of disease and 1,367
for other reasons) supplied the reasons for smoking cessation at
Q05. The relative risks for all-cause mortality among participants
who quit smoking due to illness compared to never smokers was
3.54 (95% CI, 2.87–4.36), higher than that for participants who
continued smoking (1.78; 95% CI, 1.57–2.00). The relative risk
for lung cancer-related deaths among new quitters who quit due
to illness was 6.55 (95% CI, 3.44–12.47), higher than that for
continuous smokers (3.36; 95% CI, 2.19–5.15). Furthermore, of
3,378 participants who quit smoking at Q10, 2,713 reported
the reasons for quitting (1,387 for disease and 1,326 for other
reasons). The relative risks among new quitters due to illness
were the greatest for both all-cause mortality (2.95; 95% CI,
2.48–3.50) and lung cancer-related deaths (7.90; 95% CI,
4.55–13.73).
Table 2. Information on medical history and daily cigarette consumption
Sex=Changes in smoking status Number of participants









NS→NS 8,797 949 (10.8) —
FS→FS 8,787 1,298 (14.8) 16 (19.8)
CS→FS 2,950 570 (19.3) 20 (38.4) 893 (30.3)
CS→CS 16,870 1,808 (10.7) 22 (13.3)
Period 2
(Q05→Q10)b
NS→NS 7,314 1,111 (15.2) —
FS→FS 9,773 2,056 (21.0) 23 (12.5)
CS→FS 2,853 770 (27.0) 24 (11.8) 1,314 (46.1)




NS→NS 41,352 2,851 (6.9) —
FS→FS 650 79 (12.2) 9 (8.8)
CS→FS 587 71 (12.1) 12 (9.8) 58 (9.9)
CS→CS 1,811 138 (7.6) 16 (9.8)
Period 2
(Q05→Q10)b
NS→NS 37,049 4,234 (11.4) —
FS→FS 969 184 (19.0) 14 (9.1)
CS→FS 525 86 (16.4) 15 (8.6) 73 (13.9)
CS→CS 1,333 153 (11.5) 15 (7.9)
CS, current smoker; FS, former smoker; NS, never smoker.
aChanges of smoking status from baseline survey to 5-year follow-up survey.
bChanges of smoking status from 5-year follow-up survey to 10-year follow-up survey.
cDiseases of medical history refers to a history of any following ones: cancer, diabetes mellitus, stroke, ischemic heart disease, and hepatitis or cirrhosis.
dThe definition of history means the recent five years in 5-year follow-up survey, while it means all the past until Q10 in 10-year follow-up survey.
eMean (standard deviation).
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DISCUSSION
This population-based prospective study evaluated the impact
of smoking status change on mortality in middle-aged Japanese
adults. Our principal finding was that relative risk estimates for
both all-cause and lung cancer-specific mortality among former
smokers were higher in model 2 than in model 1, suggesting
that the relative risks for former smokers become higher with
updated smoking information. This finding is considered in the
context that new quitters were reclassified as former smokers in
model 2. However, never or former smokers at baseline who
started smoking during the follow-up (never smoker→current
smoker and former smoker→current smoker) were reclassified
as current smokers in model 2. New quitters in model 2 were
generally considered to include those who found quitting easy
due to being light smokers or who quit due to life-threatening
illnesses. The results for former smokers in model 2 depend on
the balance of the two groups. Risks for those who quit due to
life-threatening illnesses were indeed high, but we could not
determine if the risk for new quitters who had been light
smokers was higher or lower than that for persistent former
smokers.























Model 1a Never smoker 11,290 (24.0) 159,712 (24.4) 1,190 (16.9) 745 Reference — 51 (7.5) 32 Reference —
Former smoker 11,257 (23.9) 155,830 (23.8) 1,728 (24.5) 1,109 1.22 (1.12–1.32) 122 (18.0) 78 1.90 (1.34–2.72)
Current smoker 24,497 (52.1) 338,145 (51.7) 4,121 (58.5) 1,219 1.79 (1.66–1.92) 504 (74.4) 149 4.70 (3.43–6.44)
Total 47,044 (100) 653,687 (100) 7,039 (100) 1,077 — — 677 (100) 104 — —
Model 2b Never smoker — — 151,642 (23.2) 1,073 (15.2) 708 Reference — 42 (6.2) 28 Reference —
Former smoker — — 194,948 (29.8) 2,551 (36.2) 1,309 1.42 (1.31–1.54) 228 (33.7) 117 2.98 (2.09–4.24)
Current smoker — — 307,097 (47.0) 3,415 (48.5) 1,112 1.74 (1.61–1.89) 407 (60.1) 133 4.69 (3.32–6.62)
Total — — 653,687 (100) 7,039 (100) 1,077 — — 677 (100) 104 — —
Women
Model 1a Never smoker 47,649 (92.2) 690,072 (92.3) 3,214 (87.7) 466 Reference — 155 (80.3) 22 Reference —
Former smoker 882 (1.7) 12,563 (1.7) 92 (2.5) 732 1.43 (1.13–1.81) 3 (1.6) 24 0.77 (0.19–3.13)
Current smoker 3,172 (6.1) 44,891 (6.0) 357 (9.7) 795 1.93 (1.70–2.19) 35 (18.1) 78 3.28 (2.12–5.05)
Total 51,703 (100) 747,526 (100) 3,663 (100) 490 — — 193 (100) 26 — —
Model 2b Never smoker — — 683,568 (91.4) 3,176 (86.7) 465 Reference — 152 (78.8) 22 Reference —
Former smoker — — 21,504 (2.9) 173 (4.7) 804 1.46 (1.23–1.73) 10 (5.2) 47 1.83 (0.92–3.64)
Current smoker — — 42,453 (5.7) 314 (8.6) 740 1.91 (1.67–2.19) 31 (16.1) 73 3.21 (2.03–5.07)
Total — — 747,526 (100) 3,663 (100) 490 — — 193 (100) 26 — —
CI, confidence interval.
aModel 1 used information on smoking status only from baseline.
bModel 2 used updated smoking status from all three surveys.
cAdjusted for age, area, alcohol consumption, body mass index, medication, history of hypertension, history of diabetes, leisure-time sports, coffee consumption,
and green tea consumption.























NS→NS 50,149 246,874 1,055 427 Reference — 58 23 Reference —
FS→FS 9,437 45,765 450 983 1.34 (1.17–1.54) 41 90 1.77 (1.08–2.90)
CS→FS
Allc 3,537 16,880 257 1,522 2.40 (2.05–2.80) 39 231 5.45 (3.34–8.90)
Illnessd 951 4,383 119 2,715 3.54 (2.87–4.36) 15 342 6.55 (3.44–12.47)
Otherse 1,367 6,616 63 952 1.53 (1.17–2.00) 16 242 5.97 (3.18–11.22)
CS→CS 18,681 90,825 899 990 1.78 (1.57–2.00) 109 120 3.36 (2.19–5.15)
Period 3b
NS→NS 44,363 217,093 1,312 604 Reference — 64 29 Reference —
FS→FS 10,742 51,494 724 1,406 1.42 (1.26–1.60) 51 99 2.11 (1.33–3.35)
CS→FS
Allc 3,378 16,014 312 1,948 2.14 (1.86–2.47) 44 275 6.59 (4.38–9.91)
Illnessd 1,387 6,428 191 2,971 2.95 (2.48–3.50) 24 373 7.90 (4.55–13.73)
Otherse 1,326 6,416 75 1,169 1.43 (1.12–1.83) 12 187 5.04 (2.55–9.94)
CS→CS 13,458 64,696 881 1,362 1.96 (1.75–2.20) 131 202 6.49 (4.08–10.31)
CI, confidence interval; CS, current smoker; FS, former smoker; NS, never smoker.
aPeriod 2 used smoking status from Q00 and Q05, starting at Q05 survey and followed up for five years.
bPeriod 3 used smoking status from Q05 and Q10, starting at Q10 survey and followed up for five years.
cAll refers to the participants wo quit smoking during two adjacent surveys.
dIllness refers to the participants who quit smoking due to illness during two adjacent surveys.
eOthers refers to the participants who quit smoking due to other reasons during two adjacent surveys.
fAdjusted for sex, age, and public health center area.
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Overall, the risk for former smokers become higher in model 2.
The relative risk for all-cause mortality among new quitters was
significantly higher than that among persistent quitters (Table 4).
Among those new quitters who quit due to illness, the relative
risk for all-cause mortality was much higher than that for
persistent quitters. The increase in relative risk for lung cancer-
related death between new quitters and persistent quitters was the
same as that for all-cause mortality. Additionally, due to never
smokers who started smoking during the follow-up (never
smoker→current smoker, n = 566; 0.6% of the sample), the
crude mortality for never smokers for men, which served as the
reference, was overestimated in model 1 because those current
smokers were considered never smokers. Therefore, the relative
risks among former smokers in model 2 were higher than those in
model 1.
Compared to those in model 1, the relative risks for all-cause
mortality among current smokers of both sexes were unchanged
in model 2 after updating smoking status. First, the relative risks
among new quitters who quit due to disease were higher than
those for continuous smokers. Second, the relative risks of new
quitters who quit for other reasons were lower than those for
continuous smokers, except for lung cancer in Period 2. After
reclassifying new quitters from current smokers to former
smokers in model 2, the relative risk was unaffected by new
quitters with both higher risk (current smoker→former smoker
with disease) and lower risk (current smoker→former smoker
others), which may explain why the relative risks for current
smokers in model 2 remained essentially unchanged compared to
those for model 1.
Previous studies using both single and multiple surveys often
used one approach to the use of smoking information.5,7,10–14
Here, smoking status was ascertained more than once for most
participants, similar to the British Doctors’ Study, which was
initiated in 1951 and followed participants with questionnaires
administered in 1957, 1966, 1971, 1978, 1991, and 2001.14 The
interval between any two surveys was irregular, and the shortest
one was 6 years. In contrast, the interval was fixed at 5 years in
the present study, shorter than any in the British Doctors’ study.
Additionally, the British Doctors’ Study did not compare the
impact between the two approaches. Akiba (1994) used data from
the Life Span Study (LSS), a large cohort study of atomic bomb
survivors in Hiroshima and Nagasaki, and information on
smoking habits collected from five sources was consolidated.
Risks of lung cancer and cancer in other major sites were
evaluated to compare smoking-related risk estimates obtained
from two approaches: one with smoking information limited to
that available from the first survey (similar to our model 1), and
another that incorporated all available information (similar to our
model 2).15 Compared to Akiba’s results, our estimates for lung
cancer risk were much larger based on using updated smoking
information among former smokers.15 This difference can be
explained partially by the fact that the proportion of our subjects
whose information was obtained from multiple surveys was 92%,
greater than the 42% rate in Akiba’s study. Another possible
explanation is that the smoking cessation rate during follow-up
in our study was higher than that in Akiba’s study due to the
different time periods.
The relative risk for former smokers will decrease further by
excluding new high-risk quitters who quit due to illness because
the relative risk for new quitters due to illness has a higher value,
while that for new quitters due to other reasons has a lower value.
The health benefits of smoking cessation could be anticipated,
especially for those who quit smoking without disease,13,17 but
there remains much to examine to understand the changes in risk
occurring after cessation.
Although the present study design was improved using
multiple surveys, we could not simulate a case-control study
because information on smoking status from a case-control study
can be obtained retrospectively, so the correct classification of
smoking status can help determine the effects of cessation more
accurately. However, we conducted repeated assessments of
smoking status in a cohort to mitigate misclassification, and
we did not gather information immediately before the events
occurred. According to the feasibility of a cohort study, we could
not collect information more frequently by decreasing the interval
to less than 5 years.
This study has some inherent limitations. First, as with
smoking status, the adjustment factors, such as drinking status
and body mass index, were also time-dependent. We fixed the
adjustment factors during the follow-up for analysis not only to
focus on the changes in smoking status but also for technical
reasons. Second, we did not adjust for any socioeconomic factor
in both models 1 and 2 because there was no information on
socioeconomic status available in questionnaires.
Conclusion
From a large population-based cohort, we clearly demonstrated
that the relative risks of all-cause and lung cancer-specific
mortality among former smokers become higher using updated
smoking status data from repeated surveys during a long-term
follow-up. Importantly, smokers who quit due to illness had
higher relative risks than did those who continued smoking. The
relative risks for all-cause mortality and mortality due to lung
cancer among current smokers of both sexes were unchanged
using updated smoking status.
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